+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Role of topotecan, vinorelbine, thiotepa and gemcitabine chemotherapy in relapsed/refractory adult acute leukemia



Role of topotecan, vinorelbine, thiotepa and gemcitabine chemotherapy in relapsed/refractory adult acute leukemia



Leukemia and Lymphoma 56(10): 2962-2964




(PDF emailed within 0-6 h: $19.90)

Accession: 058791611

Download citation: RISBibTeXText

PMID: 25721752

DOI: 10.3109/10428194.2015.1018250


Related references

Remission re-induction chemotherapy with clofarabine, topotecan, thiotepa, and vinorelbine for patients with relapsed or refractory leukemia. Pediatric Blood and Cancer 54(5): 687-693, 2010

Phase II trial of clofarabine with topotecan, vinorelbine, and thiotepa in pediatric patients with relapsed or refractory acute leukemia. Pediatric Blood and Cancer 61(3): 431-435, 2014

A phase I and pharmacodynamic study of sequential topotecan and etoposide in adult patients with refractory/relapsed acute leukemia. Blood 92(10 SUPPL 1 PART 1-2): 234A, Nov 15, 1998

A multicenter phase 2 study of risk-adjusted salvage chemotherapy incorporating vinorelbine and gemcitabine for relapsed and refractory lymphoma. Cancer 113(11): 3192-3198, 2008

A multicentre phase-II feasibility study evaluating gemcitabine/vinorelbine / prednisolone combination chemotherapy in relapsed / refractory Hodgkin's lymphoma. Journal of the College of Physicians and Surgeons--Pakistan 23(6): 397-400, 2013

VM-26 and cytarabine combination chemotherapy in refractory or relapsed adult acute lymphoblastic leukemia. Haematologica 69(6): 747-751, 1984

Treatment of refractory and relapsed adult acute leukemia using a uniform chemotherapy protocol. Leukemia and Lymphoma 11(5-6): 393-398, 1993

Combination chemotherapy with gemcitabine and vinorelbine in the treatment of relapsed or refractory diffuse large B-cell lymphoma: a phase-II trial by the Hellenic Cooperative Oncology Group. European Journal of Haematology 75(2): 124-129, 2005

Vm 26 teniposide and cytarabine combination chemotherapy in refractory or relapsed adult acute lymphoblastic leukemia. Haematologica: 747-751, 1984

Time-sequential chemotherapy as treatment for refractory or relapsed adult acute myeloid leukemia. Blood 92(10 SUPPL 1 PART 1-2): 217B, Nov 15, 1998

Treatment of refractory/relapsed adult acute lymphoblastic leukemia with bortezomib-based chemotherapy. International Journal of General Medicine 8: 211-214, 2015

Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML): Japan Adult Leukemia Study Group (JALSG)-AML206 study. Cancer Science 102(7): 1358-1365, 2011

Cyclophosphamide, ara-C and topotecan (CAT) for patients with refractory or relapsed acute leukemia. Leukemia and Lymphoma 36(5-6): 479-484, 2000

Hematopoietic growth factor (G-CSF or GM-CSF) after salvage chemotherapy in refractory or relapsed adult de novo acute leukemia. Leukemia and Lymphoma 20(3-4): 321-326, 1996

Rituximab in combination with vinorelbine/gemcitabine chemotherapy in patients with primary refractory or early relapsed T cell rich B cell lymphoma. A pilot study. Leukemia Research 27(12): 1097-1099, December, 2003